Novartis investors intensify pressure on the company's M&A strategy after a string of trial failures, Michelle Carnahan ...

Novartis investors are placing increased pressure on Novartis’ dealmaking strategy after facing setbacks to drugs acquired ...

The health care industry has invested heavily in point solutions ($100 billion). We have one tool for scheduling, another for ...

Model N's Jesse Mendelsohn examines the growing stakes surrounding the 340B Drug Pricing Program — and how claims data, rebate models and simmering legal challenges are influencing manufacturer ...

This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr ...

GLP-1 medications might be most well-known as weight-loss options, but they were originally developed as a treatment for type 2 diabetes. For many patients, the drugs remain a highly effective ...

Ray Pressburger is the Global Industry Lead for Accenture in Life Sciences. He has spent over 20 years working across the industry on commercialization and transformations across nearly every ...

A patient checks in and sits down, closer to their own health than they will be at almost any other point in the year, turning over the questions they mean to ask, the decision they're about to make.

The biopharmaceutical industry is undergoing a profound transformation, driven by the emergence of agentic artificial intelligence (AI). Unlike traditional AI models that require continuous human ...

Governance pressure is intensifying at Novartis, with calls to penalize dealmakers for failed M&A and align executive pay ...

Dr. Elena Christofides on why treatment failure in diabetes should trigger a cortisol screen — not an assumption of non-adherence. Artisan Partners' David Samra calls for a board shake-up at Novartis ...

For more than 20 years now, companies in the life sciences industry have waved the banner of patient-centricity, spending on advisory boards, listening sessions and even “patient weeks” in their ...